Govt Considers Ban On Two Antibiotics For Poultry And Animal Feed Supplements

New Delhi: The government is considering banning the production, import and distribution of the chloramphenicol and nitrofurans classes of antibiotics for use in any food-producing animal rearing system, after it has been found that these drugs are misused in poultry and other animal feed supplements.

Both are commonly used antibiotics to treat bacterial and urinary infections in humans.

The Drugs Technical Advisory Board (DTAB) – India’s top drug advisory body – will soon take up the issue of imposing a total ban on the import and production of chloramphenicol and nitrofuran drugs for use in the food- producing systems, people in the know told ET.

The matter was discussed by the Drugs Consultative Committee (DCC) earlier where the members were of the view that drugs were often being misused for poultry and other animal feed supplements. Therefore, the committee agreed with a proposal for banning the import, production, distribution and sales of these drugs.

The Marine Products Export Development Authority (MPEDA) had also submitted a representation to the Department of Animal Husbandry and Dairying last year raising the same issue, after which the matter was considered by the Empowered Committee on Animal Health.

Following this, the Ministry of Fisheries, Animal Husbandry and Dairying issued a memorandum last year in October to the MPEDA, stating that the committee had no objection to a total ban on import, production, distribution and sales of chloramphenicol and nitrofuran drugs for use in any food producing animal rearing systems.

The MPEDA then asked the Ministry of Health & Family Welfare to take the necessary steps to implement the committee’s recommendation.

“The matter will finally be taken up by the DTAB after which a notification to this effect is likely to come,” said a person in the know.

Related Posts

Puresta launches EVERQ, AI-powered skin-health platform

Puresta Lifestyle Private Limited announced the launch of EVERQ, an AI-powered skin-health platform designed to bring skin assessment, dermatologist consultations, personalised treatment and ongoing skincare together in one connected journey.…

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell interventions that have not been approved for routine clinical use, including those offered for autism, should not be provided as routine, standard or commercial clinical services, the advisory…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre

US FDA launches expedited IND Pilot, begins accepting applications

US FDA launches expedited IND Pilot, begins accepting applications

PIL in SC seeks time-bound probe, stringent action against fake drug networks

PIL in SC seeks time-bound probe, stringent action against fake drug networks

Ghaziabad: Fake supplement racket busted, 5 held

Ghaziabad: Fake supplement racket busted, 5 held

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records